Discover the significance of PIRA in multiple sclerosis and how pharmacists enhance early detection and patient care in MS management.
Ryan Fuller, PharmD
Advertisement
Articles by Ryan Fuller, PharmD
Understanding the Multiple Sclerosis Disease Continuum and the Consequences of Untreated Progression
Explore innovative strategies for identifying and managing multiple sclerosis through expert insights on biomarker-driven care and clinical practices.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Immuneering Panel & CEO Insights: Atebimetinib Raises the Bar for Survival and Quality of Life in Pancreatic Cancer
2
Positive Phase 2a Trial Supports FDA Clearance of StemCyte’s HPC Therapy for Long COVID Patients
3
Centanafadine for Treatment of ADHD in Children, Adolescents, and Adults Accepted By FDA for Priority Review
4
January 2026 Product Updates
5